Inventor · disambiguated record
Matthew Burger
Also filed as: BURGER MATTHEW · BURGER MATTHEW T
33 granted patents·22 pending applications·380 citations·filing 1997–2024
97Inventor score
Top patents by PatentIndex Score
55 records- 0195US8168794B2Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2009·Granted May 1, 2012·36 cites·14 claims
- 0294US9242969B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jan 26, 2016·35 cites·17 claims
- 0394US8329732B2Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2009·Granted Dec 11, 2012·36 cites·21 claims
- 0494US8217035B2Pyrimidine derivatives used as PI-3-kinase inhibitorsBURGER MATTHEW·Filed 2007·Granted Jul 10, 2012·61 cites·7 claims
- 0592US8563549B2Pyrimidine derivatives used as PI-3 kinase inhibitorsBURGER MATTHEW·Filed 2012·Granted Oct 22, 2013·43 cites·16 claims
- 0689US10709712B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Jul 14, 2020·3 cites·7 claims
- 0789US8822497B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2008·Granted Sep 2, 2014·10 cites·9 claims
- 0889US8592455B2Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2011·Granted Nov 26, 2013·11 cites·8 claims
- 0989US7326711B2Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agentsCHIRON CORP·Filed 2004·Granted Feb 5, 2008·29 cites·21 claims
- 1088US12171839B2Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2022·Granted Dec 24, 2024·1 cites·11 claims
- 1187US8829193B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2012·Granted Sep 9, 2014·5 cites·11 claims
- 1284US10245267B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Apr 2, 2019·3 cites·4 claims
- 1384US9694016B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jul 4, 2017·5 cites·8 claims
- 1484US7345046B2Heteroaryl-fused pyrimidinyl compounds as anticancer agentsCHIRON CORP·Filed 2004·Granted Mar 18, 2008·21 cites·40 claims
- 1584US7163924B2Ketolide derivativesCHIRON CORP·Filed 2004·Granted Jan 16, 2007·20 cites·35 claims
- 1682US10167279B2Compounds and compositions as RAF kinase inhibitorsNOVARTIS AG·Filed 2015·Granted Jan 1, 2019·3 cites·17 claims
- 1782US9079889B2Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2013·Granted Jul 14, 2015·4 cites·2 claims
- 1882US8987457B2Ring-substituted N-pyridinyl amides as kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Mar 24, 2015·5 cites·9 claims
- 1981US8735424B2Bicyclic kinase inhibitorsBURGER MATTHEW·Filed 2009·Granted May 27, 2014·5 cites·17 claims
- 2080US8173647B2PI 3-kinase inhibitors and methods of their useATALLAH GORDANA·Filed 2008·Granted May 8, 2012·9 cites·6 claims
- 2179US9809610B2Compounds and compositions as kinase inhibitorsBURGER MATTHEW T·Filed 2017·Granted Nov 7, 2017·2 cites·6 claims
- 2279US7332476B2Pyridyl substituted ketolide antibioticsNOVARTIS AG·Filed 2004·Granted Feb 19, 2008·16 cites·46 claims
- 2379US2025064964A1Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2478US9573969B2Compounds and compositions as kinase inhibitorsBURGER MATTHEW T·Filed 2015·Granted Feb 21, 2017·2 cites·8 claims
- 2577US6756359B2C12 modified erythromycin macrolides and ketolides having antibacterial activityCHIRON CORP·Filed 2002·Granted Jun 29, 2004·11 cites·10 claims
- 2677US2024299574A1Antibodies to pmel17 and conjugates thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2776US11779649B2Antibodies to PMEL17 and conjugates thereofNOVARTIS AG·Filed 2019·Granted Oct 10, 2023·1 cites·55 claims
- 2876US10464969B2Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymeraseNOVARTIS AG·Filed 2017·Granted Nov 5, 2019·1 cites·21 claims
- 2976US2024189439A1Antibodies to pmel17 and conjugates thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3070US10377770B2Tricyclic compounds and compositions as kinase inhibitorsNOVARTIS AG·Filed 2016·Granted Aug 13, 2019·1 cites·30 claims
- 3170US9173883B2Ring-substituted N-pyridinyl amides as kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Nov 3, 2015·1 cites·20 claims
- 3266US10604547B2Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymeraseNOVARTIS AG·Filed 2019·Granted Mar 31, 2020·0 cites·15 claims
- 3360US2025387504A1Antibody-drug conjugates of antineoplastic compounds and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3458US2025179063A2Selective bcl-xl protac compounds and methods of useHERNER ANDRAS·Filed 2022·Application pending·0 cites
- 3558US2024376094A2Selective bcl-xl protac compounds and methods of useHERNER ANDRAS·Filed 2022·Application pending·0 cites
- 3657US11357864B2Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·23 claims
- 3757US2023092679A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3857US2023081720A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3955US8759338B2Heterocyclic kinase inhibitorsBURGER MATTHEW·Filed 2009·Granted Jun 24, 2014·0 cites·10 claims
- 4055US2008069817A1Heteroaryl-fused pyrimidinyl compounds as anticancer agentsCHIRON CORP·Filed 2007·Application pending·0 cites
- 4153US2024269304A1Bcl-xl inhibitor antibody-drug conjugates and methods of use thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 4251US2014249135A1Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2014·Application pending·0 cites
- 4351US2015315150A1Kinase inhibitors and methods of their useBURGER MATTHEW T·Filed 2015·Application pending·0 cites
- 4450US2023091510A1Antibody drug conjugates having linkers comprising hydrophilic groupsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 4550US2021228731A1Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4649US2014228363A1Tetrasubstituted cyclohexyl compounds as kinase inhibitorsBURGER MATTHEW·Filed 2014·Application pending·0 cites
- 4749US2024042051A1Mcl-1 inhibitor antibody-drug conjugates and methods of useROCCHETTI FRANCESCA·Filed 2021·Application pending·0 cites
- 4845US2015150873A1Novel ring-substituted n-pyridinyl amides as kinase inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 4944US2012225061A1Tetrasubstituted cyclohexyl compounds as kinase inhibitorsBURGER MATTHEW·Filed 2012·Application pending·0 cites
- 5043US2015336960A1Aryl-substituted fused bicyclic pyridazine compoundsBURGER MATTHEW·Filed 2013·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →